Strategic trends of pharmaceutical companies: A growth model through regional focus and inter-regional alliances

Akinori Nakashima; Kota Kodama; Shintaro Sengoku

doi:10.1016/j.drudis.2023.103611

Strategic trends of pharmaceutical companies: A growth model through regional focus and inter-regional alliances

Drug Discov Today. 2023 Jul;28(7):103611. doi: 10.1016/j.drudis.2023.103611. Epub 2023 May 8.

Authors

Akinori Nakashima¹, Kota Kodama², Shintaro Sengoku³

Affiliations

¹ Department of Innovation Science, School of Environment and Society, Tokyo Institute of Technology, Meguro-ku, Tokyo, Japan.
² School of Data Science, Nagoya City University, Nagoya, Japan.
³ Department of Innovation Science, School of Environment and Society, Tokyo Institute of Technology, Meguro-ku, Tokyo, Japan. Electronic address: sengoku.s.aa@m.titech.ac.jp.

PMID: 37164307
DOI: 10.1016/j.drudis.2023.103611

Abstract

Pharmaceutical companies face challenges in business continuity resulting from declining research and development productivity. This study examines the relationship between two strategic pillars: region and therapeutic area, while considering company size. The results indicate that a therapeutic area focus is an effective strategy for small/medium-sized companies, whereas a regional focus is effective for larger companies. These findings highlight the limitations of the traditional global pharmaceutical model from 2004 to 2018 and aim to contribute to the future corporate strategic planning of these companies.

Keywords: pharmaceutical company; regional strategy; research and development; therapeutic area strategy.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Commerce*
Drug Industry* / methods
Pharmaceutical Preparations
Small Business

Substances

Pharmaceutical Preparations